Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jeanesse Scerri"'
Autor:
Jeanesse Scerri, Christian Scerri, Felix Schäfer-Ruoff, Simon Fink, Markus Templin, Godfrey Grech
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Protein expression, activation and stability are regulated through inter-connected signal transduction pathways resulting in specific cellular states. This study sought to differentiate between the complex mechanisms of intrinsic and acquired trastuz
Externí odkaz:
https://doaj.org/article/88bc182dd81e471287768db22eecb0fc
Autor:
Márton Szoboszlay, Laetitia Schramm, David Pinzauti, Jeanesse Scerri, Anna Sandionigi, Manuele Biazzo
Publikováno v:
Microorganisms, Vol 11, Iss 3, p 804 (2023)
Nanopore sequencing is a promising technology used for 16S rRNA gene amplicon sequencing as it can provide full-length 16S reads and has a low up-front cost that allows research groups to set up their own sequencing workflows. To assess whether Nanop
Externí odkaz:
https://doaj.org/article/c786fd00bee744529d3a8bec381ee425
Publikováno v:
Journal of Epidemiology and Global Health, Vol 3, Iss 3 (2019)
Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen worldwide. Malta is one of the countries with the highest MRSA prevalence in Europe, as identified from hospital blood cultures [1]. However, community prevalence of MR
Externí odkaz:
https://doaj.org/article/f70eb6b05f314118af3535f335499a7f
Autor:
Mark Abela, Jessica Debattista, Jeanesse Scerri, KENTARO YAMAGATA, Felice Tiziana, Melanie R Zammit Burg, Mark A Sammut, Robert G Xuereb, Victor Grech, Christian Scerri, lorenzo I monserrat, Michael Papadakis
Publikováno v:
Circulation. 144
Introduction: Cascade family screening in inherited heart disease is often reserved for probands with a clinical diagnosis. This study assessed the yield of family screening in a national cardiac screening program, comparing a clinical and a clinical
Publikováno v:
Methods. 158:86-91
Patient stratification, prognosis and disease monitoring are three important aspects of personalized cancer medicine. With traditional serum tumour protein biomarkers showing lack of specificity and sensitivity, and tumour heterogeneity affecting the
Autor:
Estelle Pujos-Guillot, Paolo Tieri, José Basílio, Harald H.H.W. Schmidt, Martin Kuiper, Johannes A. Schmid, Åsmund Flobak, Feng He, Christian Franken, Jeanesse Scerri, Juan Albino Méndez Pérez, Steven Watterson, Tadeja Režen, Damjana Rozman, Kristel Van Steen, Blandine Comte, Nissim Harel, Nataša Debeljak, Sona Vasudevan, Jan Baumbach, Arriel Benis
Publikováno v:
Network and Systems Medicine
Network and Systems Medicine, 2020, 3 (1), pp.67-90. ⟨10.1089/nsm.2020.0004⟩
Network and systems medicine Online 3 (2020). doi:10.1089/nsm.2020.0004
info:cnr-pdr/source/autori:Blandine Comte 1, Jan Baumbach 2, Arriel Benis 3, José Basílio 4, Nata?a Debeljak 5, Åsmund Flobak 6 7, Christian Franken 8 9, Nissim Harel 3, Feng He 10 11, Martin Kuiper 12, Juan Albino Méndez Pérez 13, Estelle Pujos-Guillot 1, Tadeja Re?en 14, Damjana Rozman 14, Johannes A Schmid 4, Jeanesse Scerri 15, Paolo Tieri 16, Kristel Van Steen 17, Sona Vasudevan 18, Steven Watterson 19, Harald H H W Schmidt 20/titolo:Network and Systems Medicine: Position Paper of the European Collaboration on Science and Technology Action on Open Multiscale Systems Medicine/doi:10.1089%2Fnsm.2020.0004/rivista:Network and systems medicine Online/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:3
Network and Systems Medicine, 2020, 3 (1), pp.67-90. ⟨10.1089/nsm.2020.0004⟩
Network and systems medicine Online 3 (2020). doi:10.1089/nsm.2020.0004
info:cnr-pdr/source/autori:Blandine Comte 1, Jan Baumbach 2, Arriel Benis 3, José Basílio 4, Nata?a Debeljak 5, Åsmund Flobak 6 7, Christian Franken 8 9, Nissim Harel 3, Feng He 10 11, Martin Kuiper 12, Juan Albino Méndez Pérez 13, Estelle Pujos-Guillot 1, Tadeja Re?en 14, Damjana Rozman 14, Johannes A Schmid 4, Jeanesse Scerri 15, Paolo Tieri 16, Kristel Van Steen 17, Sona Vasudevan 18, Steven Watterson 19, Harald H H W Schmidt 20/titolo:Network and Systems Medicine: Position Paper of the European Collaboration on Science and Technology Action on Open Multiscale Systems Medicine/doi:10.1089%2Fnsm.2020.0004/rivista:Network and systems medicine Online/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:3
Introduction: Network and systems medicine has rapidly evolved over the past decade, thanks to computational and integrative tools, which stem in part from systems biology. However, major challenges and hurdles are still present regarding validation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b09e5a4bbcb6a7fe330417bf4fcae0
https://hal.inrae.fr/hal-02957776/file/2020_Comte_Network_Syst_Med.pdf
https://hal.inrae.fr/hal-02957776/file/2020_Comte_Network_Syst_Med.pdf
Publikováno v:
Cancer Research. 80:1915-1915
Introduction The widespread clinical use of monoclonal antibodies such as trastuzumab in personalized medicine, targeting upstream proteins such as receptors with cascading effects on downstream signaling, elicits the importance of studying the phosp
Publikováno v:
Journal of visualized experiments : JoVE. (138)
Nucleic acid degradation in archival tissue, tumor heterogeneity, and a lack of fresh frozen tissue specimens can negatively impact cancer diagnostic services in pathology laboratories worldwide. Gene amplification and expression diagnostic testing u
Publikováno v:
Journal of Epidemiology and Global Health, Vol 3, Iss 3, Pp 165-173 (2013)
Methicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen worldwide. Malta is one of the countries with the highest MRSA prevalence in Europe, as identified from hospital blood cultures [1]. However, community prevalence of MR